Search Results - "Filetti, Sebastiano"

ROLE OF IMAGING INVESTIGATIONS IN DETECTING THYROID NODULE MALIGNANCY. A RETROSPECTIVE STUDY.

Authors: COREȚCHI, D. JALBĂ (SÎRBU), G.-A. POPA, C.-A. et al.

Source: Annals of the University Dunarea de Jos of Galati: Fascicle XV: Physical Education & Sport Management. 2024 Supplement, Vol. 2, p105-124.

Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial.

Authors: Pratley, Richard E. Nauck, Michael Bailey, Timothy et al.

Source: Lancet. 4/24/2010, Vol. 375 Issue 9724, p1447-1456. 10p. 1 Diagram, 3 Charts, 3 Graphs.

Subjects: Type 2 diabetes treatment, Drug efficacy, Glucagon-like peptide 1, Clinical drug trials, Hypoglycemic agents, Metformin

A global network for network medicine.

Authors: Maron, Bradley A. Altucci, Lucia Balligand, Jean-Luc et al.

Source: NPJ Systems Biology & Applications. 8/31/2020, Vol. 6 Issue 1, pN.PAG-N.PAG. 1p.

Mutation profiles of follicular thyroid tumors by targeted sequencing.

Authors: Duan, Huanli Liu, Xiaoding Ren, Xinyu et al.

Source: Diagnostic Pathology. 5/10/2019, Vol. 14 Issue 1, p1-10. 10p.

The role of FOSL1 in stem-like cell reprogramming processes.

Authors: Pecce, Valeria Verrienti, Antonella Fiscon, Giulia et al.

Source: Scientific Reports. 7/19/2021, Vol. 11 Issue 1, p1-11. 11p.

Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedside.

Authors: Sarno, Federica Benincasa, Giuditta List, Markus et al.

Source: Clinical Epigenetics. 3/30/2021, Vol. 13 Issue 1, p1-38. 38p.

Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer.

Authors: Micali, Salvatore Bulotta, Stefania Puppin, Cinzia et al.

Source: BMC Cancer. 2014, Vol. 14 Issue 1, p1-26. 26p.

A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency.

Authors: Pecce, Valeria Sponziello, Marialuisa Damante, Giuseppe et al.

Source: PLoS Genetics. 10/15/2018, Vol. 14 Issue 10, p1-20. 20p.

Expression of PAX8 Target Genes in Papillary Thyroid Carcinoma.

Authors: Rosignolo, Francesca Sponziello, Marialuisa Durante, Cosimo et al.

Source: PLoS ONE. 6/1/2016, Vol. 11 Issue 6, p1-15. 15p.

Sonographic Risk Stratification Systems for Thyroid Nodules as Rule-Out Tests in Older Adults.

Authors: Grani, Giorgio Brenta, Gabriela Trimboli, Pierpaolo et al.

Source: Cancers. Sep2020, Vol. 12 Issue 9, p2458. 1p.

Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line.

Authors: Baldan, Federica Mio, Catia Allegri, Lorenzo et al.

Source: International Journal of Endocrinology. 1/29/2015, Vol. 2015, p1-7. 7p.

Clinical Experience with Pheochromocytoma in a Single Centre Over 16 Years.

Authors: Cotesta, Dario Petramala, Luigi Serra, Valentina et al.

Source: High Blood Pressure & Cardiovascular Prevention. Dec2009, Vol. 16 Issue 4, p183-193. 11p.

Recovery of NIS expression in thyroid cancer cells by overexpression of Pax8 gene.

Authors: Presta, Ivan Arturi, Franco Ferretti, Elisabetta et al.

Source: BMC Cancer. 2005, Vol. 5, p80-10. 10p. 1 Diagram, 1 Chart, 1 Graph.

Cytotoxic effects of Gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells.

Authors: Celano, Marilena Calvagno, Maria Grazia Bulotta, Stefania et al.

Source: BMC Cancer. 2004, Vol. 4, p63-5. 5p. 1 Diagram, 2 Graphs.

Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the Thyroid.

Authors: Pecce, Valeria Verrienti, Antonella Abballe, Luana et al.

Source: Cancers. Jul2020, Vol. 12 Issue 7, p1892. 1p.

Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk Stratification.

Authors: Tallini, Giovanni De Leo, Antonio Repaci, Andrea et al.

Source: Cancers. Jan2020, Vol. 12 Issue 1, p246. 1p.

Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation?

Authors: Chiefari, Eusebio Brunetti, Antonio Arturi, Franco et al.

Source: BMC Cancer. 2002, Vol. 2, p1-4. 4p. 3 Diagrams, 1 Graph.

Mutational analysis of Peroxiredoxin IV: exclusion of a positional candidate for multinodular goitre.

Authors: Giardina, Emiliano Capon, Francesca D'Apice, M. Rosaria et al.

Source: BMC Medical Genetics. 2002, Vol. 3, p5-4. 4p. 1 Diagram, 1 Chart.

The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells.

Authors: Allegri, Lorenzo Baldan, Federica Roy, Sudeshna et al.

Source: Scientific Reports. 5/14/2019, Vol. 9 Issue 1, pN.PAG-N.PAG. 1p.

p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.

Authors: Moretti, Fabiola Farsetti, Antonella Soddu, Silvia et al.

Source: Oncogene. 2/13/97, Vol. 14 Issue 6, p729. 12p.